Citius Pharmaceuticals, Inc. (CTXR) stock
Close on Nov 17, 2026Market cap $14.24MP/E –Yield –
Earnings
Citius Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Citius Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2027ended Dec 31, 2026 | Feb 12, 2027Expected | – | – | – | – |
| Q4 FY2026ended Sep 30, 2026 | Oct 26, 2026after the close | – | – | – | Release |
| Q3 FY2026ended Jun 30, 2026 | Aug 14, 2026during market hours | $1.50M | – | -$0.34 | Release |
| Q2 FY2026ended Mar 31, 2026 | May 15, 2026during market hours | $1.70M | – | -$0.95 | Release |
| Q1 FY2026ended Dec 31, 2025 | Feb 13, 2026before the open | – | – | – | Release |
| Q4 FY2025ended Sep 30, 2025 | Dec 23, 2025during market hours | – | – | – | Release |
| Q3 FY2025ended Jun 30, 2025 | Aug 12, 2025during market hours | – | – | -$0.80 | Release |
| Q2 FY2025ended Mar 31, 2025 | May 14, 2025during market hours | – | – | -$1.27 | Release |
| Q4 FY2024ended Sep 30, 2024 | Dec 27, 2024during market hours | – | – | – | Release |
| Q3 FY2024ended Jun 30, 2024 | Aug 12, 2024during market hours | – | – | -$0.06 | Release |
| Q2 FY2024ended Mar 31, 2024 | May 14, 2024during market hours | – | – | -$0.05 | Release |
| Q1 FY2024ended Dec 31, 2023 | Feb 15, 2024before the open | – | – | -$0.06 | Release |
| Q3 FY2023ended Jun 30, 2023 | Aug 15, 2023before the open | – | – | -$0.06 | Release |
| Q1 FY2023ended Dec 31, 2022 | Feb 10, 2023during market hours | – | – | -$0.02 | Release |
| Q4 FY2022ended Sep 30, 2022 | Dec 22, 2022during market hours | – | – | – | Release |
| Q3 FY2022ended Jun 30, 2022 | Aug 11, 2022during market hours | – | – | -$0.06 | Release |
| Q2 FY2022ended Mar 31, 2022 | May 12, 2022during market hours | – | – | -$0.05 | Release |
| Q1 FY2022ended Dec 31, 2021 | Feb 10, 2022during market hours | – | – | -$0.06 | Release |
| Q4 FY2021ended Sep 30, 2021 | Dec 15, 2021during market hours | – | – | – | Release |
| Q3 FY2021ended Jun 30, 2021 | Aug 12, 2021during market hours | – | – | – | Filing |
| Q2 FY2021ended Mar 31, 2021 | May 13, 2021before the open | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Citius Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Citius Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Citius Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Results
- News
- News
- Results
- News
- News
- News
- News
- News
- News
- Results
- Results
- Update
See a number that looks wrong?